·          Bolivia, Paraguay, Thailand, Malaysia, Curaçao, Azerbaijan and Kazakhstan, are the new countries where Yondelis® has been approved for Soft Tissue Sarcoma (STS)

·          Yondelis® has also been approved in Kazakhstan for the treatment of relapsed platinum-sensitive ovarian cancer (ROC)

·          With these 8 new marketing authorizations Yondelis^® is already approved in 21 countries outside the EEA (European Economic Area) in addition to the 30 countries of the EEA and Switzerland